A nurse provides teaching for a patient who is newly diagnosed with Parkinson's disease. Which statement by the patient indicates understanding of the drug therapy for this disease?

Choice A reason: Hyperkalemia, or elevated potassium levels in the blood, is not typically seen in patients with SIADH. SIADH is primarily characterized by water retention and the resultant dilution of electrolytes, most notably sodium. Potassium levels are not directly affected by the antidiuretic hormone (ADH) abnormalities present in SIADH, and thus hyperkalemia is not an expected finding.

Choice B reason: Hypokalemia, which refers to low potassium levels in the blood, is also not a characteristic feature of SIADH. While potassium imbalances can occur due to a variety of conditions and medications, they are not the hallmark of SIADH. The syndrome's primary effect on electrolyte balance involves sodium, not potassium.

Choice C reason: Hyponatremia, or low sodium levels in the blood, is the defining feature of SIADH. In this condition, excessive secretion of antidiuretic hormone (ADH) leads to increased water reabsorption in the kidneys. This excess water dilutes the sodium in the bloodstream, leading to hyponatremia. The resulting imbalance can cause symptoms ranging from mild (such as headache and nausea) to severe (such as seizures and altered mental status), depending on the degree of sodium depletion.

Choice D reason: Hypercalcemia, or high calcium levels in the blood, is not associated with SIADH. The condition of SIADH affects water and sodium balance due to inappropriate ADH secretion but does not typically influence calcium levels. Hypercalcemia can be seen in other conditions, such as hyperparathyroidism or malignancies, but it is not related to the pathophysiology of SIADH.

Choice A reason: Methotrexate is an immunosuppressive drug commonly used to treat rheumatoid arthritis. One of the most important topics to address when teaching a patient about methotrexate is the risk for infection. Methotrexate can suppress the immune system, making patients more susceptible to infections. Patients should be educated on the signs and symptoms of infection, the importance of maintaining good hygiene, avoiding contact with sick individuals, and reporting any signs of infection to their healthcare provider promptly. This helps in early detection and management of infections, which can be severe in immunocompromised patients.

Choice B reason: The need for sunblock is important for patients taking certain medications that cause photosensitivity, but methotrexate is not typically associated with a high risk of photosensitivity. While sun protection is generally advisable, it is not the most critical teaching point for methotrexate.

Choice C reason: The need for an eye examination is crucial for patients taking medications like hydroxychloroquine, which can affect the eyes. However, methotrexate does not commonly require routine eye examinations, making this a lower priority in patient education.

Choice D reason: The risk for developing esophagitis is more relevant for patients taking medications that can cause irritation or damage to the esophagus, such as bisphosphonates. While methotrexate can cause gastrointestinal side effects, esophagitis is not a primary concern, making this less critical compared to the risk of infection.